{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:44:08Z","timestamp":1787021048309,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"DOI":"10.1186\/s40942-026-00856-9","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T12:16:36Z","timestamp":1776860196000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevention of postoperative proliferative vitreoretinopathy in complex retinal detachments with serial intravitreal methotrexate injections"],"prefix":"10.1186","volume":"12","author":[{"given":"Lucas Valad\u00e3o de Brito","family":"Soares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago Nelson de Oliveira","family":"Rassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wener Passarinho","family":"Cella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Maia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"issue":"1","key":"856_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0039-6257(98)00023-X","volume":"43","author":"JC Pastor","year":"1998","unstructured":"Pastor JC. Proliferative vitreoretinopathy. Surv Ophthalmol. 1998;43(1):3\u201318.","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"856_CR2","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/sj.eye.6700194","volume":"16","author":"D Charteris","year":"2002","unstructured":"Charteris D, Sethi C, Lewis G, Fisher S. Proliferative vitreoretinopathy: developments in adjunctive treatment and retinal pathology. Eye (Lond). 2002;16(4):369\u201374.","journal-title":"Eye (Lond)"},{"issue":"5","key":"856_CR3","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/eye.2014.21","volume":"28","author":"K Ghasemi Falavarjani","year":"2014","unstructured":"Ghasemi Falavarjani K, Hashemi M, Modarres M, Hadavand Khani A. Intrasilicone oil injection of bevacizumab at the end of retinal reattachment surgery for severe proliferative vitreoretinopathy. Eye (Lond). 2014;28(5):576\u201380.","journal-title":"Eye (Lond)"},{"issue":"3","key":"856_CR4","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/S0161-6420(95)31007-X","volume":"102","author":"S Fekrat","year":"1995","unstructured":"Fekrat S, de Juan E Jr, Campochiaro PA. The effect of oral 13-cis-retinoic acid on retinal redetachment after surgical repair in eyes with proliferative vitreoretinopathy. Ophthalmology. 1995;102(3):412\u20138.","journal-title":"Ophthalmology"},{"issue":"8","key":"856_CR5","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1001\/archopht.1986.01050200132067","volume":"104","author":"M Lemor","year":"1986","unstructured":"Lemor M, Yeo JH, Glaser BM. Oral colchicine for the treatment of experimental traction retinal detachment. Arch Ophthalmol. 1986;104(8):1226\u20139.","journal-title":"Arch Ophthalmol"},{"key":"856_CR6","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.2147\/OPTH.S27896","volume":"6","author":"GP Giuliari","year":"2012","unstructured":"Giuliari GP, Sadaka A. Proliferative vitreoretinopathy: current and emerging treatments. Clin Ophthalmol. 2012;6:1325\u201333.","journal-title":"Clin Ophthalmol"},{"key":"856_CR7","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.2147\/OPTH.S111893","volume":"10","author":"A Sadaka","year":"2016","unstructured":"Sadaka A, Sisk RA, Osher JM, Toygar O, Duncan MK, Riemann CD. Intravitreal methotrexate infusion for proliferative vitreoretinopathy. Clin Ophthalmol. 2016;10:1811\u20137.","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"856_CR8","doi-asserted-by":"crossref","first-page":"260","DOI":"10.18502\/jovr.v16i2.9089","volume":"16","author":"F Abdi","year":"2021","unstructured":"Abdi F, Mohammadi S, Ghasemi Falavarjani K. Intravitreal methotrexate. J Ophthalmic Vis Res. 2021;16(2):260\u20137.","journal-title":"J Ophthalmic Vis Res"},{"issue":"5","key":"856_CR9","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1136\/bjophthalmol-2011-300581","volume":"96","author":"D Mitry","year":"2012","unstructured":"Mitry D, Awan MA, Borooah S, et al. Surgical outcome and risk stratification for primary retinal detachment repair. Br J Ophthalmol. 2012;96(5):730\u20134.","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"856_CR10","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1007\/s00417-015-3007-1","volume":"253","author":"S Manna","year":"2015","unstructured":"Manna S, Banerjee R, Augsburger JJ, et al. Sustained-release methotrexate intraocular implant: pharmacokinetics and toxicity in rabbit eyes. Graefes Arch Clin Exp Ophthalmol. 2015;253(8):1297\u2013305.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"856_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.51329\/mehdiophthal1452","volume":"11","author":"JH Aziz","year":"2022","unstructured":"Aziz JH, Zaki MA, El-Shazly AAEF, et al. Intravitreal methotrexate infusion for prophylaxis of proliferative vitreoretinopathy after pars plana vitrectomy. Med Hypothesis Discov Innov Ophthalmol. 2022;11(3):95\u2013103.","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"issue":"10","key":"856_CR12","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1167\/iovs.16-20912","volume":"58","author":"D Amarnani","year":"2017","unstructured":"Amarnani D, Machuca-Parra AI, Wong LL, et al. Effect of methotrexate on an in vitro patient-derived model of proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 2017;58(10):3940\u20137.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"856_CR13","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3109\/02713683.2010.513089","volume":"35","author":"NK Palakurthi","year":"2010","unstructured":"Palakurthi NK, Krishnamoorthy M, Augsburger JJ, et al. Kinetics of methotrexate for therapeutic treatment of intraocular lymphoma. Curr Eye Res. 2010;35(12):1105\u201315.","journal-title":"Curr Eye Res"},{"issue":"1","key":"856_CR14","doi-asserted-by":"publisher","first-page":"e000293","DOI":"10.1136\/bmjophth-2019-000293","volume":"4","author":"JD Benner","year":"2019","unstructured":"Benner JD, Dao D, Butler JW, Hamill KI. Intravitreal methotrexate for proliferative vitreoretinopathy. BMJ Open Ophthalmol. 2019;4(1):e000293.","journal-title":"BMJ Open Ophthalmol"},{"key":"856_CR15","first-page":"3648134","volume":"2021","author":"S El Baha","year":"2021","unstructured":"El Baha S, Leila M, Amr A, Lolah MMA. Outcomes of vitrectomy with or without intravitreal methotrexate for proliferative vitreoretinopathy. J Ophthalmol. 2021;2021:3648134.","journal-title":"J Ophthalmol"},{"key":"856_CR16","doi-asserted-by":"publisher","first-page":"28842","DOI":"10.1038\/s41598-024-79708-1","volume":"14","author":"R Nourinia","year":"2024","unstructured":"Nourinia R, Safi S, Mohammadpour M, et al. Effects of repeated intra-silicone oil injections of methotrexate on proliferative vitreoretinopathy grade C: a multicenter randomized controlled trial. Sci Rep. 2024;14:28842.","journal-title":"Sci Rep"},{"issue":"2","key":"856_CR17","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.survophthal.2025.09.015","volume":"71","author":"I Kocak","year":"2026","unstructured":"Kocak I, Sayin N, Bayramoglu SE, Thalib L. Effect of methotrexate in preventing retinal detachment after proliferative vitreoretinopathy surgery: a systematic review and meta-analysis. Surv Ophthalmol. 2026;71(2):572\u201381.","journal-title":"Surv Ophthalmol"},{"issue":"11","key":"856_CR18","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.4103\/ijo.IJO_481_17","volume":"65","author":"B Takkar","year":"2017","unstructured":"Takkar B, Temkar S, Gaur N, et al. Retinal shortening: ultrasonic evaluation of proliferative vitreoretinopathy. Indian J Ophthalmol. 2017;65(11):1172.","journal-title":"Indian J Ophthalmol"},{"issue":"3","key":"856_CR19","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.oret.2022.10.013","volume":"7","author":"A Ullah","year":"2023","unstructured":"Ullah A, Toth CA, Burnett HW, et al. Low-dose intravitreal methotrexate for proliferative vitreoretinopathy. Ophthalmol Retina. 2023;7(3):282\u20138.","journal-title":"Ophthalmol Retina"},{"issue":"9","key":"856_CR20","first-page":"869","volume":"3","author":"L Gibson","year":"2019","unstructured":"Gibson L, Nguyen A, Ridgeway J, et al. Postoperative methotrexate to reduce reoperation rate and improve vision. Ophthalmol Retina. 2019;3(9):869\u201376.","journal-title":"Ophthalmol Retina"},{"issue":"2","key":"856_CR21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0002-9394(14)76695-4","volume":"112","author":"R Machemer","year":"1991","unstructured":"Machemer R, Aaberg TM, Freeman HM, et al. An updated classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol. 1991;112(2):159\u201365.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"856_CR22","first-page":"269","volume":"107","author":"Y Jin","year":"2000","unstructured":"Jin Y. Traumatic proliferative vitreoretinopathy: clinical and histopathological observations. Ophthalmology. 2000;107(2):269\u201376.","journal-title":"Ophthalmology"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-026-00856-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-026-00856-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-026-00856-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:33:48Z","timestamp":1781649228000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40942-026-00856-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["856"],"URL":"https:\/\/doi.org\/10.1186\/s40942-026-00856-9","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"21 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study adhered to the principles outlined in the Declaration of Helsinki and was approved by the Ethics Committee of Hospital S\u00e3o Domingos. Written informed consent was obtained from all participants prior to enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from all participants prior to enrollment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"83"}}